Vivonoetics and Beddit Partner to Provide Contact-Free Monitoring of Sleep and Vital Signs to Pharmaceutical Clinical Trials
SAN DIEGO--(BUSINESS WIRE)--
Vivonoetics Inc., developer of VivoSense® clinical research management
and analysis software, and Beddit, Inc., innovators in sleep and vital
sign monitoring technology, announced today that they have partnered to
provide pharmaceutical companies and research organizations with a
practical and cost effective solution for long-term monitoring of sleep
and vital signs, enabling more effective and efficient evaluation of new
and existing treatments.
Objective measurements of traditional patient reported outcomes,
obtained in naturalistic settings significantly improves drug
development economics and time-lines. Long-term monitoring of sleep,
together with long-term trends in vital signs, are powerful indicators
that measure the therapeutic value of new drugs and help identify
possible adverse events. Objective information about real-world patient
sleep patterns, together with long term cardio-respiratory information,
can be incorporated into clinical trials for inclusion/exclusion
screening purposes, or as primary or secondary outcome measures.
Currently available tools for pharmaceutical researchers and healthcare
practitioners to monitor sleep or vital signs are based on the
application of one or more sensors to the body during sleep. The need to
apply and wear sensor systems results in poor patient compliance. Thus
current technologies are particularly unsuitable for long-term
The Beddit Pro system is easily installed in the subjects own bed and
passively monitors night time sleep status, without the need to wear
sensors or be encumbered by wires. This makes Beddit Pro perfectly
suited for long-term monitoring. Using ballistocardiographic (BCG)
technology, the contact-free Beddit Pro monitoring system continuously
measures both night time sleep profile and cardio-respiratory vital
signs. Acquired sensor data are automatically uploaded to a secure cloud
for subsequent analysis in VivoSense®. This reduces errors and allows
studies to run more effectively and efficiently.
VivoSense® is a powerful software system that captures data from a
variety of wearable sensor platforms and provides efficient analysis,
visualization and management of long-term, non-controlled data.
VivoSense® is a validated platform and is 21 CFR Part 11 compliant and
specifically designed for use in clinical trials and research studies.
VivoSense® can be rapidly customized and configured to generate accurate
and meaningful pharmacodynamics and statistics from physiological
A new consumer version of the Beddit sensor may be pre-ordered at
discounted prices on Indiegogo: Order
here - http://igg.me/at/beddit-sleep-tracker/x/4399575
Vivonoetics Inc., founded in 2009, and based in San Diego, CA, is a
leader in body-worn technology for clinical research. Through the use of
Vivonoetics core laboratory services and VivoSense® technology,
pharmaceutical researchers can obtain high quality data solutions
describing a patient's physiological status in ambulatory and home
settings. Vivonoetics has supported research and clinical trials using
VivoSense® at over 300 leading research and academic institutions across
a wide range of disease states, including sleep disordered breathing,
congestive heart failure, chronic obstructive pulmonary disease and
cystic fibrosis. For more information, visit www.vivonoetics.com.
Beddit, Inc., founded in 2006, has offices in Finland and Silicon
Valley. Beddit develops and markets revolutionary products for sleep and
wellness tracking. Utilizing special sensor technology and sophisticated
signal analysis algorithms, Beddit has created products for tracking
sleep, heart rate and breathing without any disturbing wearable sensors.
Beddit products are globally used by medical and training professionals
as well as by consumers. For more information, visit www.beddit.com
Lance Myers, email@example.comAnnina
Source: Vivonoetics Inc.